{"bundle_type":"pith_open_graph_bundle","bundle_version":"1.0","pith_number":"pith:2017:GAHXFXB54BULOAEEBTA5WMSYFM","short_pith_number":"pith:GAHXFXB5","canonical_record":{"source":{"id":"1705.05183","kind":"arxiv","version":2},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"cs.CL","submitted_at":"2017-05-15T12:29:52Z","cross_cats_sorted":[],"title_canon_sha256":"7764cfc320acb8d8e33059cd24e4c2a2b96d8b1b842ee7034b88997a3d2f4ff9","abstract_canon_sha256":"686b0be3bd48b989188facc385d9ea3613e8447a9c1c079e2390866e411147a8"},"schema_version":"1.0"},"canonical_sha256":"300f72dc3de068b700840cc1db32582b133e3d24a396cd6e804fbacf2e12ae19","source":{"kind":"arxiv","id":"1705.05183","version":2},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1705.05183","created_at":"2026-05-18T00:44:06Z"},{"alias_kind":"arxiv_version","alias_value":"1705.05183v2","created_at":"2026-05-18T00:44:06Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1705.05183","created_at":"2026-05-18T00:44:06Z"},{"alias_kind":"pith_short_12","alias_value":"GAHXFXB54BUL","created_at":"2026-05-18T12:31:15Z"},{"alias_kind":"pith_short_16","alias_value":"GAHXFXB54BULOAEE","created_at":"2026-05-18T12:31:15Z"},{"alias_kind":"pith_short_8","alias_value":"GAHXFXB5","created_at":"2026-05-18T12:31:15Z"}],"events":[{"event_type":"record_created","subject_pith_number":"pith:2017:GAHXFXB54BULOAEEBTA5WMSYFM","target":"record","payload":{"canonical_record":{"source":{"id":"1705.05183","kind":"arxiv","version":2},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"cs.CL","submitted_at":"2017-05-15T12:29:52Z","cross_cats_sorted":[],"title_canon_sha256":"7764cfc320acb8d8e33059cd24e4c2a2b96d8b1b842ee7034b88997a3d2f4ff9","abstract_canon_sha256":"686b0be3bd48b989188facc385d9ea3613e8447a9c1c079e2390866e411147a8"},"schema_version":"1.0"},"canonical_sha256":"300f72dc3de068b700840cc1db32582b133e3d24a396cd6e804fbacf2e12ae19","receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-05-18T00:44:06.590468Z","signature_b64":"jIfD4dg+JfPNxmOpV6tRDt0GWy+p5xWsvaznx+eF6zfCyB2PGOmWOwAyG5E6yaj07iQBQ3qEbQajKAZqa2pOCA==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"300f72dc3de068b700840cc1db32582b133e3d24a396cd6e804fbacf2e12ae19","last_reissued_at":"2026-05-18T00:44:06.589998Z","signature_status":"signed_v1","first_computed_at":"2026-05-18T00:44:06.589998Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"source_kind":"arxiv","source_id":"1705.05183","source_version":2,"attestation_state":"computed"},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-18T00:44:06Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"s+7QaVPQ51LR8x3jTSL4CP168uxMVuf0fujWECzGhphS7zMnaLyxJZgjo8peZR/EbGuGoaoaVVMVHaDPEWaPAw==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-06-08T23:11:16.597656Z"},"content_sha256":"fc760179ff611914ba17d7b8e22b03069058eae28a251942710fdbe0f90d884c","schema_version":"1.0","event_id":"sha256:fc760179ff611914ba17d7b8e22b03069058eae28a251942710fdbe0f90d884c"},{"event_type":"graph_snapshot","subject_pith_number":"pith:2017:GAHXFXB54BULOAEEBTA5WMSYFM","target":"graph","payload":{"graph_snapshot":{"paper":{"title":"Representation learning of drug and disease terms for drug repositioning","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":[],"primary_cat":"cs.CL","authors_text":"Ashish Anand, Sahil Manchanda","submitted_at":"2017-05-15T12:29:52Z","abstract_excerpt":"Drug repositioning (DR) refers to identification of novel indications for the approved drugs. The requirement of huge investment of time as well as money and risk of failure in clinical trials have led to surge in interest in drug repositioning. DR exploits two major aspects associated with drugs and diseases: existence of similarity among drugs and among diseases due to their shared involved genes or pathways or common biological effects. Existing methods of identifying drug-disease association majorly rely on the information available in the structured databases only. On the other hand, abun"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1705.05183","kind":"arxiv","version":2},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"verdict_id":null},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-18T00:44:06Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"NOdxUXdUIWCZfUqg3akqH+NoUeO+ExMQnDKodO47G9BI4RhV1Gz8AtNWXQz+km9a6uSntusQIU2uKemB8xStCw==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-06-08T23:11:16.597987Z"},"content_sha256":"7db50a61751fe67361cb5a1f19db767dacec1f28c3d06ddd5406015743d800b8","schema_version":"1.0","event_id":"sha256:7db50a61751fe67361cb5a1f19db767dacec1f28c3d06ddd5406015743d800b8"}],"timestamp_proofs":[],"mirror_hints":[{"mirror_type":"https","name":"Pith Resolver","base_url":"https://pith.science","bundle_url":"https://pith.science/pith/GAHXFXB54BULOAEEBTA5WMSYFM/bundle.json","state_url":"https://pith.science/pith/GAHXFXB54BULOAEEBTA5WMSYFM/state.json","well_known_bundle_url":"https://pith.science/.well-known/pith/GAHXFXB54BULOAEEBTA5WMSYFM/bundle.json","status":"primary"}],"public_keys":[{"key_id":"pith-v1-2026-05","algorithm":"ed25519","format":"raw","public_key_b64":"stVStoiQhXFxp4s2pdzPNoqVNBMojDU/fJ2db5S3CbM=","public_key_hex":"b2d552b68890857171a78b36a5dccf368a953413288c353f7c9d9d6f94b709b3","fingerprint_sha256_b32_first128bits":"RVFV5Z2OI2J3ZUO7ERDEBCYNKS","fingerprint_sha256_hex":"8d4b5ee74e4693bcd1df2446408b0d54","rotates_at":null,"url":"https://pith.science/pith-signing-key.json","notes":"Pith uses this Ed25519 key to sign canonical record SHA-256 digests. Verify with: ed25519_verify(public_key, message=canonical_sha256_bytes, signature=base64decode(signature_b64))."}],"merge_version":"pith-open-graph-merge-v1","built_at":"2026-06-08T23:11:16Z","links":{"resolver":"https://pith.science/pith/GAHXFXB54BULOAEEBTA5WMSYFM","bundle":"https://pith.science/pith/GAHXFXB54BULOAEEBTA5WMSYFM/bundle.json","state":"https://pith.science/pith/GAHXFXB54BULOAEEBTA5WMSYFM/state.json","well_known_bundle":"https://pith.science/.well-known/pith/GAHXFXB54BULOAEEBTA5WMSYFM/bundle.json"},"state":{"state_type":"pith_open_graph_state","state_version":"1.0","pith_number":"pith:2017:GAHXFXB54BULOAEEBTA5WMSYFM","merge_version":"pith-open-graph-merge-v1","event_count":2,"valid_event_count":2,"invalid_event_count":0,"equivocation_count":0,"current":{"canonical_record":{"metadata":{"abstract_canon_sha256":"686b0be3bd48b989188facc385d9ea3613e8447a9c1c079e2390866e411147a8","cross_cats_sorted":[],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"cs.CL","submitted_at":"2017-05-15T12:29:52Z","title_canon_sha256":"7764cfc320acb8d8e33059cd24e4c2a2b96d8b1b842ee7034b88997a3d2f4ff9"},"schema_version":"1.0","source":{"id":"1705.05183","kind":"arxiv","version":2}},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1705.05183","created_at":"2026-05-18T00:44:06Z"},{"alias_kind":"arxiv_version","alias_value":"1705.05183v2","created_at":"2026-05-18T00:44:06Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1705.05183","created_at":"2026-05-18T00:44:06Z"},{"alias_kind":"pith_short_12","alias_value":"GAHXFXB54BUL","created_at":"2026-05-18T12:31:15Z"},{"alias_kind":"pith_short_16","alias_value":"GAHXFXB54BULOAEE","created_at":"2026-05-18T12:31:15Z"},{"alias_kind":"pith_short_8","alias_value":"GAHXFXB5","created_at":"2026-05-18T12:31:15Z"}],"graph_snapshots":[{"event_id":"sha256:7db50a61751fe67361cb5a1f19db767dacec1f28c3d06ddd5406015743d800b8","target":"graph","created_at":"2026-05-18T00:44:06Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"graph_snapshot":{"author_claims":{"count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","strong_count":0},"builder_version":"pith-number-builder-2026-05-17-v1","claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"paper":{"abstract_excerpt":"Drug repositioning (DR) refers to identification of novel indications for the approved drugs. The requirement of huge investment of time as well as money and risk of failure in clinical trials have led to surge in interest in drug repositioning. DR exploits two major aspects associated with drugs and diseases: existence of similarity among drugs and among diseases due to their shared involved genes or pathways or common biological effects. Existing methods of identifying drug-disease association majorly rely on the information available in the structured databases only. On the other hand, abun","authors_text":"Ashish Anand, Sahil Manchanda","cross_cats":[],"headline":"","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"cs.CL","submitted_at":"2017-05-15T12:29:52Z","title":"Representation learning of drug and disease terms for drug repositioning"},"references":{"count":0,"internal_anchors":0,"resolved_work":0,"sample":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1705.05183","kind":"arxiv","version":2},"verdict":{"created_at":null,"id":null,"model_set":{},"one_line_summary":"","pipeline_version":null,"pith_extraction_headline":"","strongest_claim":"","weakest_assumption":""}},"verdict_id":null}}],"author_attestations":[],"timestamp_anchors":[],"storage_attestations":[],"citation_signatures":[],"replication_records":[],"corrections":[],"mirror_hints":[],"record_created":{"event_id":"sha256:fc760179ff611914ba17d7b8e22b03069058eae28a251942710fdbe0f90d884c","target":"record","created_at":"2026-05-18T00:44:06Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"attestation_state":"computed","canonical_record":{"metadata":{"abstract_canon_sha256":"686b0be3bd48b989188facc385d9ea3613e8447a9c1c079e2390866e411147a8","cross_cats_sorted":[],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"cs.CL","submitted_at":"2017-05-15T12:29:52Z","title_canon_sha256":"7764cfc320acb8d8e33059cd24e4c2a2b96d8b1b842ee7034b88997a3d2f4ff9"},"schema_version":"1.0","source":{"id":"1705.05183","kind":"arxiv","version":2}},"canonical_sha256":"300f72dc3de068b700840cc1db32582b133e3d24a396cd6e804fbacf2e12ae19","receipt":{"algorithm":"ed25519","builder_version":"pith-number-builder-2026-05-17-v1","canonical_sha256":"300f72dc3de068b700840cc1db32582b133e3d24a396cd6e804fbacf2e12ae19","first_computed_at":"2026-05-18T00:44:06.589998Z","key_id":"pith-v1-2026-05","kind":"pith_receipt","last_reissued_at":"2026-05-18T00:44:06.589998Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","receipt_version":"0.3","signature_b64":"jIfD4dg+JfPNxmOpV6tRDt0GWy+p5xWsvaznx+eF6zfCyB2PGOmWOwAyG5E6yaj07iQBQ3qEbQajKAZqa2pOCA==","signature_status":"signed_v1","signed_at":"2026-05-18T00:44:06.590468Z","signed_message":"canonical_sha256_bytes"},"source_id":"1705.05183","source_kind":"arxiv","source_version":2}}},"equivocations":[],"invalid_events":[],"applied_event_ids":["sha256:fc760179ff611914ba17d7b8e22b03069058eae28a251942710fdbe0f90d884c","sha256:7db50a61751fe67361cb5a1f19db767dacec1f28c3d06ddd5406015743d800b8"],"state_sha256":"179597a78acab16a36aa4c2fe9593237d3bd344027f078fc4c049fb47da40356"},"bundle_signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"KkoFpPWnUQUauF7KGA0JkqIteKH9q/59Y133URh5oeT5hHfwWMe04lrhSpWp5A8O4hwnM9Vd+7mBlp/X4hfrDA==","signed_message":"bundle_sha256_bytes","signed_at":"2026-06-08T23:11:16.599784Z","bundle_sha256":"0c8fa5ca8bdfa48c6ddad2b5ce6f4fe62527bdd15f6c0764399d29cb02692248"}}